Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
Group Sign-on Letter to CMS Requesting Revision of Interpretation of NCD for NGS for Advanced Cancer
-
ACMG Responds to FDA’s Approval for DTC Testing for Three BRCA Gene Mutations
-
ACMG Comments to CMS on Proposed NCD for Coverage of NGS for Medicare Beneficiaries with Advanced Cancer (CAG-00450N)
-
ACMG Applauds Supreme Court Decision on Gene Patents
-
ACMG Joins Amicus Brief in Mayo v. Prometheus to Counter Patents on Observations of Natural Phenomena
-
ACMG Comments to SACGHS on Patenting and Licensing Practices
-
ACMG Joins Legal Complaint Against Myriad Genetics for Patent on BRCA Genetic Information